RadOncQuestions
Release date: June 1, 2017 Expiration date: June 1, 2026
Content Review: May 15, 2017; June 17, 2020
Estimated time to complete activity: Up to 98 hours
Overview
RadOncQuestions helps subscribers prepare for their Radiation Oncology Knowledge Assessment Program exams, written boards, and recertification for boards. A question bank for radiation oncologists physicians provides up-to-date questions, and explanations with answers.
Target Audience
The target audience consists of physicians specializing in radiation oncology.
Accreditation and Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Interstate Postgraduate Medical Association (IPMA) and RadOncQuestions. The IPMA is accredited by the ACCME to provide continuing medical education for physicians.
The Interstate Postgraduate Medical Association designates this enduring material for a maximum of 155 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, RadOncQuestions has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
MOC Part II CME Activity
Radiology
Commercial Support
None
Disclosure Information
As a provider dedicated to independent education and accredited by the ACCME, IPMA must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All individuals with potential to influence the content of this program have disclosed all financial relationships that have occurred in the past 24 months with ineligible companies. The disclosures have been reviewed according to policy and these declarations are listed below. All individuals with potential conflicts have been contacted as needed by IPMA staff, and issues of conflict have been discussed, managed, and mitigated.
|
Individual |
Role |
Disclosure |
|
Ashley Albert, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Ryan Bair, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
James Edward Bates, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Lauren Boreta, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Steve Braunstein, MD PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
James Broughman, MD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Jeffrey Brower, MD, PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Nicholas Damico, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Emily Daugherty, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Aharon M Feldman, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Daniel Golden, MD, MHPE |
Planner, Faculty |
No relevant relationships with ineligible companies to disclose |
|
Chelain Goodman, MD PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Andrew Jonathan Huang, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Krishan R Jethwa, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Aditya Juloori, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Mohamed Khattab, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Pericles Loannides, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Natalya Morrow, PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Nima Nabavizadeh, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Heidi Ness |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Neil Newman, MD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
William Joseph Pao, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Anna Paulsson, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Jamie Pawlowski, MD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Gaspar Perez Jimenez, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Luke Pike, MD |
Faculty |
Consultant: Blackstone, Third Rock Ventures/Dynamo Therapeutics, Myst Therapeutics |
|
Jeremy Price, MD, PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Paul Ramia, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Mark Ranck, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
David Routman, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Sonali Rudra, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Jeff Ryckman, MD, MSMP |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Virginia Marilia Candeias Santos Mareco, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Narek Shaverdian, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Ashwin Shinde, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Sumi Sinha, MD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Sarah Sittenfeld, MD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Matthew Spraker, MD, PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Gregory Stachelek, MD, PhD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Shane Steckleun, MD, PhD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Gus Stern, MD |
Planner |
No relevant relationships with ineligible companies to disclose |
|
Sam Sun, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Jessica Karen Wong, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
|
Susan Wu, MD |
Faculty |
No relevant relationships with ineligible companies to disclose |
Disclaimer
The opinions expressed in the enduring educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
All reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education program does not imply endorsement by IPMA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Privacy Policy
At IPMA, we care about providing you with tools and information to manage and protect your online privacy. IPMA retains records solely for keeping records in accordance with ACCME policies. We will not share your information with any other organizations. We will keep you informed of our CME activities. Please e-mail cmehelp@ipmameded.org if you do not want to receive any communications from us.
Copyright
© Copyright 2017 by RadOncQuestions. This also contains material copyrighted by third parties.
Contact Information
IPMA
PO Box 5474
Madison, WI 53705
608.231.9045